Polymerised Type I and II BSA have been specifically developed for use in blood grouping applications. This product is also supplied in a liquid with 0.09% sodium azide added or lyophilised format.
BSA is obtained by a proprietary Heat-Shock method, designed to prevent the excessive use of denaturing organic solvents. It undergoes a thermal inactivation during 3 hours at 65°C in order to inactivate potential viruses. Lyophilized BSA has been 0.2 µm filtered prior to being freeze-dried.
Bovine plasma used for the manufacture of this product is collected from French healthy cattle declared free from BSE disease in its clinical forms. It is sourced in EU-approved French slaughterhouses.
Disclaimer: Product image is a representation only and label details may differ from the actual product received.